The effect of the combination of bisphosphonates and conventional chemotherapy on bone metabolic markers in multiple myeloma patients

Author： Zhang Xi   Chang Chunkang   Zhao Youshan   Wu Lingyun   Zhang Zheng   Li Xiao  

Publisher： Maney Publishing

ISSN： 1024-5332

Source： Hematology, Vol.17, Iss.5, 2012-09, pp. : 255-260

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sequential or combination therapy for multiple myeloma

By Nooka Ajay   Lonial Sagar  

Expert Review of Hematology, Vol. 5, Iss. 5, 2012-10 ,pp. : 533-545

Informa Healthcare

Access to resources Recommend Favorite

The proportion of CD16+CD14dim monocytes increases with tumor cell load in bone marrow of patients with multiple myeloma

By  

Immunity, Inflammation And Disease, Vol. 3, Iss. 2, 2015-06 ,pp. : 94-102

John Wiley & Sons Inc

Access to resources Recommend Favorite

Zoledronic acid exerts its antitumor effect in multiple myeloma interfering with the bone marrow microenvironment

By Corso Alessandro   Ferretti Eleonora   Lazzarino Mario  

Hematology, Vol. 10, Iss. 3, 2005-06 ,pp. : 215-224

Maney Publishing

Access to resources Recommend Favorite

Syndecan-1 in Multiple Myeloma: Relationship to Conventional Prognostic Factors

By Aref Salah   Goda T.   El-Sherbiny M.  

Hematology, Vol. 8, Iss. 4, 2003-08 ,pp. : 221-228

Maney Publishing

Access to resources Recommend Favorite

Meningeal and cerebral involvement in multiple myeloma patients

By Patriarca F.   Zaja F.   Silvestri F.   Sperotto A.   Scalise A.   Gigli G.   Fanin R.  

Annals of Hematology, Vol. 80, Iss. 12, 2001-12 ,pp. : 758-762

Springer Publishing Company

Access to resources Recommend Favorite